Solvency II overview



Similar documents
SOLVENCY II LIFE INSURANCE

International Financial Reporting for Insurers: IFRS and U.S. GAAP September 2009 Session 25: Solvency II vs. IFRS

SOLVENCY II HEALTH INSURANCE

SOLVENCY II LIFE INSURANCE

02/06/2014. Solvency II update. Agenda. Recap: Solvency II three pillar approach. Nick Ford

Industry Briefing on Central Bank Guidelines on Preparing for Solvency II

Solvency II for Beginners

SOLVENCY II HEALTH INSURANCE

Regulations in General Insurance. Solvency II

INVESTMENT FUNDS: Funds investments. KPMG Business DialogueS November 4 th 2011

Solvency II Introduction to Pillar 3. Friday 20 th May 2016

Solvency II Pillar III Quantitative Reporting Templates (QRTs) Sinead Clarke, Eoin King 11 th December 2012

Solvency II Conference. 29 November 2011

Quick Solvency II Technical Reporting Guide. Pillar 3: What, Who and When

Texts passed by the European Council and Parliament Adapted by Member States

Solvency ii: an overview. Lloyd s July 2010

Gabriel Bernardino Chairman of EIOPA

Effects of recent changes in asbestos. on companies Christopher Diamantoukos, FCAS, MAAA

SOLVENCY II ARE YOU READY AND COMPLIANT?

Making it clear Reporting and disclosure in the Solvency II world

Solvency II in practice. Speaker: Tim O Hanrahan Deputy Head, Insurance, Central Bank of Ireland 16 March 2016

Role of Actuaries in Solvency II Tamsin Abbey

KPMG Business DialogueS

An update on QIS5. Agenda 4/27/2010. Context, scope and timelines The draft Technical Specification Getting into gear Questions

Preparing for ORSA - Some practical issues Speaker:

Hot Topic FS Regulatory Centre of Excellence, 2 December Hot Topic. Solvency II requirements published

Consultation Paper on the Proposal for Guidelines on submission of information to national competent authorities

SOLVENCY II GENERAL INSURANCE

Solvency II. Impacts on asset managers and servicers. Financial Services Asset Management.

Cash Management Group Solvency II and Money Market Funds

Insurance Roadshow London, October Solvency 2 Update

EIOPACP 13/011. Guidelines on PreApplication of Internal Models

Directors & Officers (D&O) liability policy primer and claim modeling potential. Presenters. Purpose of D&O insurance

1. INTRODUCTION AND PURPOSE

Preparing for Solvency II Time for asset managers and asset servicers to act. Thierry Flamand Partner Advisory & Consulting Deloitte

Solvency II. Solvency II implemented on 1 January Why replace Solvency I? To which insurance companies does the new framework apply?

Newsletter. Solvency II update. Solvency II requirements published. 1. Further clarification on the Long-Term Guarantee Package;

Solvency II Standard Model for Health Insurance Business

Solvency II. SUPERVISORY RePORTING & DISCLOSURE workshop. 15 & 16 May Lloyd s

Introduction to Solvency II

Regulatory Solvency Assessment of Property/Casualty Insurance Companies in the United States

SCOR inform - April Life (re)insurance under Solvency II

Solvency Assessment and Management: Capital Requirements Discussion Document 58 (v 3) SCR Structure Credit and Counterparty Default Risk

COMMISSION DELEGATED DECISION (EU) / of

Central Bank of Ireland Guidelines on Preparing for Solvency II Pre-application for Internal Models

10 November Leading business advisers. Solvency II Breakfast Briefing

IAIS Insurance Core Principle 16

Consultation Paper CP43/15 Solvency II: external audit of the public disclosure requirement

FSA UK Country Report

ORSA - The heart of Solvency II

CRO Forum Paper on the Own Risk and Solvency Assessment (ORSA): Leveraging regulatory requirements to generate value. May 2012.

Insurance Groups under Solvency II

Hot Topic. Reporting requirements under Solvency II move forward

Public reporting in a Solvency II environment

Embedded Value 2014 Report

SAS AND CRYSTAL SYSTEM EMPOWERING SOLVENCY II FIAR - THE INTERNATIONAL INSURANCE-REINSURANCE FORUM 2014, BRASOV

Solvency SII switchover

SOLVENCY II Level 2 Implementing Measures

Actuarial Discipline: Threat or Opportunity?

Solvency II and catastrophe

This section outlines the Solvency II requirements for a syndicate s own risk and solvency assessment (ORSA).

Implementation of Solvency II: The dos and the don ts

Own Risk and Solvency Assessment

Assessing Sources of Funding for Insurance Risk Based Capital

2012 US Insurance ERM & ORSA Survey Key results and findings

Capital requirements for health insurance under Solvency II

Solvency II: Hot topics for life insurers from the latest draft level 2 and level 3 measures. Jim Murphy Andrew Kay

Solvency II Preparation and IMAP James Latto

Risk Management in the Insurance Industry: A Comparison of Solvency II to U.S. Insurance Regulations

Solvency II, the practical implications for asset managers and insurers

Solvency II. A closer look at the evolving process transforming the global insurance industry. kpmg.com

Solvency II benchmarking survey

List of critical errors in internal models of insurance undertakings

Solvency II Reporting EIOPA consultation on Pillar 3 disclosures

Solvency II Own Risk and Solvency Assessment (ORSA) July 2010


Questions and answers collated at the PRA s Solvency II industry briefings on 12 December 2013

Bermuda s Insurance Solvency Framework. The Roadmap to Regulatory Equivalence

Consultation Paper CP22/16 Solvency II: Monitoring model drift and standard formula SCR reporting for firms with an approved internal model

Solvency II: Implications for Loss Reserving

Solvency II guidance notes. February 2012

Positioning the internal audit function within the Solvency II framework Key challenges. Ludovic Bardon Senior Manager Audit Deloitte Luxembourg

ORSA for Insurers A Global Concept

Solvency II: An update on implementation

19/10/2012. How do you monitor. (...And why should you?) CAS Annual Meeting - Henry Jupe

Insurance Guidance Note No. 14 System of Governance - Insurance Transition to Governance Requirements established under the Solvency II Directive

Guidelines on ring-fenced funds

top issues An annual report

Introduction to Grant Thornton s General Insurance Actuarial Services

Solvency II Own risk and solvency assessment (ORSA)

Solvency II and key considerations for asset managers

Guidance for the Development of a Models-Based Solvency Framework for Canadian Life Insurance Companies

FINMA s model review approach and future challenges

Fourth study of the Solvency II standard approach

ERM from a Small Insurance Company Perspective

2 9 J AN UARY Solvency II: Landed

Latin America. Developing Solvency Regulations. Brazil

Solvency Management in Life Insurance The company s perspective

Key performance indicators

Solvency II Own Risk and Solvency Assessment (ORSA)

Transcription:

David Payne, FIA Casualty Loss Reserve Seminar 15 September 2011 INTNL-2: Solvency II Update

Antitrust Notice The Casualty Actuarial Society is committed to adhering strictly to the letter and spirit of the antitrust laws. Seminars conducted under the auspices of the CAS are designed solely to provide a forum for the expression of various points of view on topics described in the programs or agendas for such meetings. Under no circumstances shall CAS seminars be used as a means for competing companies or firms to reach any understanding expressed or implied that restricts competition or in any way impairs the ability of members to exercise independent business judgment regarding matters affecting competition. It is the responsibility of all seminar participants to be aware of antitrust regulations, to prevent any written or verbal discussions that appear to violate these laws, and to adhere in every respect to the CAS antitrust compliance policy. Page 2

Solvency II Contents What is Solvency II? How does it work? Timeline Equivalence issues impact on US Page 3

What is Solvency II? Solvency II is the new EU wide regulatory regime, due to come in force Jan 1, 2013. It is based on the 3 Pillar Basel II model from the banking industry: Pillar 1 Pillar 2 Pillar 3 Valuation principles Capital requirement SCR 1 MCR 2 Standard Formula / Internal Model Internal model approval process Must allow for all risks, including those not captured in the SCR ORSA Own risk and solvency assessment Reviewed by supervisor may impose capital add-ons Public disclosure Solvency and financial condition report Report to supervisor Transparency Market discipline 1. Solvency Capital Requirement 2. Minimum Capital Requirement Page 4

Pillar 1 Market consistent balance sheet Assets Free assets Investments: generally able to be marked to market MCR SCR Capital requirements SCR = first regulatory intervention point MCR = final regulatory intervention point Intangible assets: adjustment to remove intangible assets, e.g., DAC and Goodwill Assets Other liabilities Risk margin Deferred tax provision: balance sheet revaluation will create profit /loss, leading to an additional deferred tax asset / liability Best estimate liability Technical provisions (gross and ceded) Three building blocks, similar to new IFRS: Technical Best estimate of all future cash flows provisions Discounted at a risk-free interest rate Risk margin to capture uncertainty Page 5

Pillar 1 Solvency capital requirement Solvency capital requirement (SCR) is calibrated to achieve 99.5% probability of survival (value-at-risk) over a one-year time period Probability Best estimate Risk margin 99.5% Amount Capital Charge There are two alternative approaches for calculating the SCR: Standard formula Internal model Page 6

Pillar 1 Standard formula Factor-based calculations and stresses on Solvency II basis balance sheet amounts Broadly: Insurance Risk (premium, reserve, catastrophe, lapse) + Counterparty Risk (reinsurance, bank deposits, intermediaries etc) + Market Risk (interest rates, FX, equity, property, spread, concentration, illiquidity premium) + Operational Risk - (Diversification Benefit) Companies able to use undertaking specific parameters (USPs) in certain instances Same rules for all companies in industry one size fits all model means it likely fits no one! Latest t iteration ti given in QIS5 exercise completed in November 2010, EU report has been published Page 7

Pillar 1 QIS5 highlights Comparison of results for total industry (both life + non-life companies): Current basis QIS5 Solo entities % of total assets Capital requirement 3.1% 7.4% Available capital 10.0% 12.9% Surplus capital 6.9% 5.3% Group entities Capital requirement 4.0% 5.0% Available capital 5.8% 8.1% Surplus capital 1.8% 3.1% 1% Non-life companies Generally small reductions in technical provisions, since discounting > risk margins Risk margins typically y around 10% of technical provisions Standard formula comes out around 25% higher than internal models for groups Page 8

Pillar 1 QIS5 highlights Breakdown of risks for average non-life 1 insurer: Intangible, 0.40% Operational, 5% Non-life insurance: prem & res, 29% Market, 31% Counterparty, t 7% Non-life ins: catastrophe, 21% Life ins, 0.50% Health ins, 7% Non-life ins: lapse, 0.40% 1 Includes health products similar to non-life (workers comp, personal accident, etc.) and incidental life business Page 9

Pillar 1 Internal models Developed by the firm and needs approval from regulator, demonstrating compliance with a number of tests Partial internal model approach is allowed: Can model only specific risks that are not handled effectively by standard formula Internal model approach is likely to be preferred where similar internal models are already in use and for complex organizations (Standard formula can be penal) 234 undertakings submitted results from Internal Models in recent QIS5 exercise In order to attain internal model approval, companies must satisfy 7 tests: 1. Use test - Model must be embedded and used in the business 2. Statistical quality standards - Accuracy of data, methodology and assumptions 3. Calibration standards d - Must tbe consistent twith ithscrf framework k(995% (99.5% over 1 yr) 4. Profit and loss attribution 5. Validation test 6. Documentation standards 7. External models and data Page 10

Pillar 1 Internal models approval process Onerous process to get approval. Pre-application template has over 80 sections to complete simply laying out what will be in the submission (!!) In UK, 14 separate items will need to be submitted...thousands of pages A. Cover Letter B. Written declaration from the Board of the firm C. Copy of the Application Approval from the Board of the firm D. Results of the latest ORSA and details of the firm s business and risk strategies E. Scope of application for full and partial internal models and model F. Risk management process and risk profile G. Self-assessment H. Technical characteristics of the internal model I. External models and data J. Model governance, systems and controls incl. copy of organizational charts K. Independent review/validation report L. Policy for changing the full / partial internal model and other policies for internal model governance M. Plan for future model improvement N. Capital requirement Page 11

Pillar 2 Own Risk and Solvency Assessment (ORSA) The entirety of the processes and procedures employed to identify, assess, monitor, manage, and report the short and long term risks that the business faces or may face and to determine the own funds necessary to ensure that its overall solvency needs are met at all times. It is the firm s own view of required capital, whereas Pillar I is the regulatory view Aim is to enhance link between internal capital needs and risks business is exposed to Main focus on demonstrating good: Risk management framework Systems of internal control Corporate governance Will need to be fully documented d and independently d (externally?) assessed It is both An internal assessment process and as such should be embedded in strategic decisions An effective mechanism to demonstrate regulatory compliance around Pillar 2 Page 12

Pillar 3 Disclosures Pillar 3 requires the following disclosures: Regulatory Disclosures Regular Supervisory Reporting RSR Qualitative information to regulator Full report every three years Quantitative Reporting Template QRT Standardized financial reporting Annually in full / Quarterly to support MCR Public Disclosures Solvency and financial condition report SFCR Public disclosures at least annually Extracts from Quantitative Reporting Templates Extensive additional disclosures compared with US GAAP / SEC filings External audit may be required for some parts, no firm determination yet A written disclosure policy needs to be approved by the management body Speed of reporting required will be a particular challenge Narrative RSR and SFCR reports need to be produced within 14 weeks of year end Quantitative templates within 6 weeks for quarterly reporting, 16 for annual Page 13

Current state of play Timeline 2010 2011 2012 2013 Europe QIS5 report Apr Equivalence reviews Jul Final advice on equivalence Internal Model Application Process Jan Omnibus II published Adoption of Level 2 delegated acts Sept Feb Level 3 guidance finalized Jul Final decision on equivalence Apr Model approval decision Dec Dec (delays??) Ber rmuda US EIOPA equivalency review BSCR recalibration Internal Capital Models Economic Balance Sheet CISSA (ORSA) Enhanced disclosures Group Supervision Statutory accounting & financial reporting Reinsurance Changes to Capital Requirements Jul Oct Dec Mar Jun Dec tation Deadline cy II Implement Solven Governance & Risk Man ment (incl ORSA) Group Supervision Page 14

Third country equivalence Background Solvency II equivalence is defined at three levels: Reinsurance supervision (Article 172) Group solvency calculation (Article 227) Group supervision (Article 260) Affects Non-EU reinsurers Groups with EU parent Groups with non-eu parent Non-equivalence Equivalence May have to post collateral in EU Collateralization not required Required to use Solvency II basis for foreign entity s contribution to group solvency calculation Can rely on local capital calculation for foreign entity (eg RBC for the US) EU-level holding company needs to be established, regulated by EU supervisor Rely on domestic supervisor for group regulation Switzerland, Bermuda (all articles) and Japan (Article 172 only) have been deemed largely equivalent (ie with caveats) in recent Consultation Papers (NB this is still draft recommendation) US is not being assessed but likely to be treated under transitional arrangements, where decision deferred for a few years (maximum 5 years) to give time to prepare Page 15

Third country equivalence United States EU report identified a number of issues with assessing equivalence for US including: The lack of a single, central regulator The absence of any group supervisory framework Professional secrecy, especially with NAIC as does not act as a supervisory authority US has launched the Solvency Modernization Initiative to bring its own system up to date In particular, NAIC has just released a Consultation Paper on US version of the ORSA, requiring: 1. Documented description of the Risk Management Policy 2. Quantitative measurements of risk exposure in normal and stressed environments (certain stresses defined by NAIC) 3. Prospective solvency assessment, on regulatory and economic basis, over next 3-5 years NAIC also meeting to discuss reforms to collateralization rules Solvency II type framework coming to the US in the very near future! Page 16

Ernst & Young Assurance Tax Transactions Advisory About Ernst & Young Ernst & Young is a global leader in assurance, tax, transaction and advisory services. Worldwide, our 141,000 people are united by our shared values and an unwavering commitment to quality. We make a difference by helping our people, our clients and our wider communities achieve their potential. Ernst & Young refers to the global organization of member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients. For more information about our organization, please visit www.ey.com. Ernst & Young LLP is a client-serving member firm of Ernst & Young Global Limited operating in the US. Ernst & Young is a leader in serving the global financial services marketplace Nearly 35,000 Ernst & Young financial services professionals around the world provide integrated assurance, tax, transaction and advisory services to our asset management, banking, capital markets and insurance clients. In the Americas, Ernst & Young is the only public accounting organization with a separate business unit dedicated to the financial services marketplace. Created in 2000, the Americas Financial Services Office today includes more than 4,000 professionals at member firms in over 50 locations throughout the US, the Caribbean and Latin America. Ernst & Young professionals in our financial services practices worldwide align with key global industry groups, including Ernst & Young s Global Asset Management Center, Global Banking & Capital Markets Center, Global Insurance Center and Global Private Equity Center, which act as hubs for sharing industry-focused knowledge on current and emerging trends and regulations in order to help our clients address key issues. Our practitioners span many disciplines and provide a well-rounded understanding of business issues and challenges, as well as integrated services to our clients. With a global presence and industry-focused advice, Ernst & Young s financial services professionals provide high-quality assurance, tax, transaction and advisory services, including operations, process improvement, risk and technology, to financial services companies worldwide. It s how Ernst & Young makes a difference. 2011 Ernst & Young LLP. All Rights Reserved. This publication contains information in summary form and is therefore intended for general guidance only. It is not intended to be a substitute for detailed research or the exercise of professional judgment. Neither Ernst & Young LLP nor any other member of the global Ernst & Young organization can accept any responsibility for loss occasioned to any person acting or refraining from action as a result of any material in this publication. On any specific matter, reference should be made to the appropriate advisor.